Showing 6-10 of 16 comparative analytics:
Real-World Evidence Analysis Of The Impact Of Steroid-Eluting Implants On Healthcare Resource Use Among Chronic Rhinosinusitis Patients Undergoing Sinus Surgery

Taylor & Francis Online Published: January 20, 2022 Read the Full Manuscript >> Objective To compare healthcare resource use (HCRU) in patients undergoing sinus surgery with or without steroid-eluting sinus implants. Methods A retrospective, observational cohort study using real-world evidence data (OM1, Inc, Boston, MA, USA) was conducted on adult patients with chronic rhinosinusitis (CRS)[…]

RWD + External Control Arms for Clinical Trials & Regulatory

Wed, Sep 29, 2021 11:00 AM – 12:00 PM EDT Presenter: Richard Gliklich, MD, CEO, OM1 Register >> Real-world data (RWD) is increasingly being used to develop external control arms (ECA) for trial planning and regulatory submissions. But, what types of RWD is needed and how should it be applied to be successful? Join Dr.[…]

Dell Medical School helps develop artificial intelligence tool for knee surgery

April 2, 2021 – Austin American-Statesman Read the Full Article >> If you had osteoarthritis in your knee, how would you know when it’s the right time to have knee replacement surgery? Dell Medical School at the University of Texas helped patients at UT Health Austin’s Musculoskeletal Institute answer that question by studying a new artificial intelligence tool[…]

Validation Of A Machine Learning Approach To Estimate Systemic Lupus Erythematosus Disease Activity Index Score Categories And Application In A Real-World Dataset

BMJ Journals Published: May 20, 2021 Read the Full Manuscript >>  Objective Use of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) in routine clinical practice is inconsistent, and availability of clinician-recorded SLEDAI scores in real-world datasets is limited. This study aimed to validate a machine learning model to estimate SLEDAI score categories using clinical notes[…]

Real-World Data and External Control Arms 101

Thu, Apr 29, 2021 11:30 AM – 12:30 PM EDT Register Real-world data is increasingly being used to develop external control arms for trial planning and regulatory submissions. Understanding the basics of what they are and how they can be used effectively are critical to success. Join Dr. Richard Gliklich, CEO of OM1, as he[…]

1 2 3 4